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Accessible Summary: 
 Alcohol-related brain damage (ARBD) causes a broad range of both neurological and 
neurocognitive impairment 
 Mental health nurses are required to provide programs designed to facilitate 
individuals with chronic alcohol dependency to radically change their drinking 
behaviour, invariably with an abstinence focus. 
 No evidence was found that related to the nutritional and physical intervention needs 
of this group. 
 
 Most instruments used to access domains relevant to ARBD in terms of providing a 
comprehensive assessment have not been validated in this group 
 
Abstract 
Alcohol-related brain damage (ARBD) is primarily caused by chronic alcohol misuse and 
thiamine deficiency and results in a broad range of impairments. Despite the increasing 
incidence of ARBD in the UK in recent decades, it is currently underdiagnosed, managed 
inappropriately and treated inadequately. Moreover, information about assessments for 
individuals with ARBD is currently absent from clinical guidelines and policy documents. 
The aim of this paper was to review the evidence relating to the neurological, 
neuropsychological, psychosocial, physical and nutritional assessment of individuals with 
ARBD, to identify appropriate assessment tools which could be used to measure and monitor 
the impact of ARBD over time. A systematic online database search revealed a total of 160 
separate references, 133 of which were rejected and 2 of which could not be accessed. 25 
papers were included in the review, including 6 neuroimaging studies, 17 neuropsychological 
studies and 2 studies using psychosocial methods of assessment.  A lack of evidence for 
nutritional and physical assessment of individuals with ARBD was found. The review 
findings are inconclusive, most instruments currently used in ARBD research have not 
specifically been validated for use within an ARBD context. Further research is required to 
identify comprehensive methods of ARBD assessment. 
 
 
 
 
 
 
Introduction 
Alcohol-related brain damage (ARBD) is an umbrella term encompassing a range of 
neuropsychiatric conditions, which are caused by long term alcohol misuse and result in 
structural and functional changes to the brain (MacRae & Cox, 2003; Zahr et al, 2011). The 
aetiology of ARBD is varied and includes the direct neurotoxic effects of alcohol on the 
brain, as well as thiamine depletion (Kopelman, 2009). Severe thiamine deficiency can result 
in an acute condition known as Wernicke’s Encephalopathy (WE), which is a consequence of 
several factors including inadequate nutritional intake, malabsorption of thiamine and 
alcoholic liver disease in chronic alcoholics (Isenberg-Grzeda et al, 2012). If WE is not 
identified and treated, it can lead to Korsakoff’s Syndrome (KS), a profound amnesic 
condition associated with a range of neuropsychological and psychosocial impairments, 
including severe anterograde and retrograde amnesia, confabulation, spatiotemporal 
disorientation, executive dysfunction, anxiety and apathy (Thomson et al, 2012a). In terms of 
prognosis, Smith and Hillman (1999) proposed that recovery rates for individuals receiving 
treatment for KS can be split into quartiles, with approximately 25% recovering completely; 
25% recovering significantly; 25% recovering slightly; and 25% showing no improvement. 
Therefore, whilst the majority of individuals with KS can be expected to recover to some 
degree, around 25% will require long-term residential care (Kopelman et al, 2009). 
 
The impact of ARBD is multifaceted and includes neuropathological changes to the brain, 
neuropsychological dysfunction, reduced quality of life and depression, as well as physical 
problems related to nutritional deficiencies, damage to the liver, stomach and pancreas 
(MacRae & Cox, 2003; Zahr et al, 2011). On-going holistic assessment is therefore required 
to facilitate the development of specialist ARBD care plans (Mental Welfare Commission for 
Scotland, 2010). Consistent with this, neuropsychological, psychiatric, social, physical, and 
functional occupational therapy assessments of daily living, should be conducted following a 
period of 3-6 weeks abstinence at least every six-months over a period of 2-years, to monitor 
changes in functioning over time and determine the level of support required by the service 
user (Ryan & Butters, 1986; Bruce & Ritson, 1998; Smith & Hillman, 1999; Jacques & 
Stevenson, 2000; MacRae & Cox, 2003; Cox et al, 2004). Assessments for ARBD should 
also incorporate a means of measuring intellectual functioning, as general intelligence along 
with procedural and semantic memory may remain intact (Thomson et al, 2012). 
Despite the increasing incidence of ARBD in recent decades (Cox et al, 2004), evidence 
suggests that it is underdiagnosed, managed inappropriately and treated inadequately 
(Thomson et al, 2012b). Current ARBD service provision is recognised to be inadequate and 
there is a clear need for appropriate care pathways incorporating specialised assessment and 
rehabilitation programmes to be developed for this client group (Wilson, 2011). There is 
currently a lack of clinical guidance relating specifically to the long-term assessment and 
management of ARBD in the United Kingdom (UK) (Department of Health [DoH], 2009; 
National Institute for Clinical Excellence [NICE], 2011; Scottish Intercollegiate Guidance 
Network [SIGN], 2003). Moreover, specific information pertaining to the assessment of 
ARBD is absent from current Government alcohol strategies in the UK (Scottish 
Government, 2009; HM Government, 2012).Nevertheless, there exists general 
recommendations, for example, the Scottish Government (2007) recommends a stepped 
approach to ARBD assessment, incorporating brief screening tools such as the Mini Mental 
State Examination (MMSE; Folstein et al, 1975) and Addenbrooke’s Cognitive Assessment 
(ACE; Mathuranath et al, 2000), as well as neuropsychological assessments such as the 
Weschsler Adult Intelligence Scale (WAIS; Wechsler, 1998); the Weschsler Test of Adult 
Reading (WTAR; Wechsler, 2001); the Rey Auditory Verbal Learning Test (RAVLT; 
Schmidt, 1996); the Weschsler Memory Scale (WMS; Wechsler, 1987); and the Delis-Kaplan 
Executive Function System Subtests (Delis et al, 2001a). As appropriate care depends on the 
comprehensive assessment of ARBD, specialised assessment procedures are essential to 
ensure that high quality rehabilitation strategies are implemented and needs-based 
interventions are available to this client group (MacRae & Cox, 2003; Mental Welfare 
Commission for Scotland, 2010). Of particular importance to the mental health services is 
detection and implementation of strategies to support clients with drink problems, with 
particular emphasis on helping those with chronic alcohol dependency to stop drinking. To 
measure the extent of alcohol-induced cognitive damage to the brain caused by excessive 
alcohol consumption, mental health nurses require to have knowledge of instruments that can 
be used to measure the neurological damage that can ensue. 
 
This review will critically appraise the evidence relating to neurological, neuropsychological, 
psychosocial and physical methods of assessing individuals with ARBD. To our knowledge, 
this is the first paper to systematically review the evidence pertaining to the comprehensive 
assessment of individuals with ARBD. The key aim of this review is to identify suitable 
assessment tools which could be used in a clinical context to measure and monitor the impact 
of ARBD over time. It is important that mental health nurses understand more about 
processes of neurological assessment of quality of life, depression and social/behavioural 
functioning. Measuring cognitive impairment of those with chronic alcohol dependency is a 
role that mental health nurses may administrate, with assessment of neurological damage 
conducted in the addictions unit, outpatients department or the client’s home. Identifying 
suitable assessment tools will be achieved by evaluating the psychometric properties of the 
assessment tools used within the appraised research papers. The findings from this review 
have implications for research into methods of assessing individuals with ARBD. As part of a 
larger body of research, this review also has the potential to influence health and social care 
practice, as well as clinical guidelines and policy documents relating to the comprehensive 
assessment of ARBD in the UK and beyond. In response, a protocol may be written for 
mental health nurses to participate in monitoring improvement or deterioration in 
neurological function of clients diagnosed with ARBD. Using such validated instruments, 
success of implemented programs may be monitored in terms of success at improving client 
abstinence.  
     
Method 
The following online databases were searched to identify English language, peer-reviewed 
journal articles examining methods of assessment for individuals with alcohol-related brain 
damage: CINAHL Plus with Full Text; Health Source: Nursing/Academic Edition; 
MEDLINE; Psychology and Behavioral Sciences Collection; PsycINFO. The PRISMA 
statement presented by (Moher et al, 2010) was used to guide the literature search strategy 
(Please see Figure 1 for the PRISMA Flow Diagram). The literature search was conducted on 
June 17, 2013. No date limitations were set in order to identify all relevant online 
publications. An initial browse on Google Scholar using the search terms “alcohol-related 
brain damage/Korsakoff*” AND “assessment” revealed that the existing evidence is focused 
mainly on the neuropsychological assessment of cognitive functioning in individuals with 
alcohol-related brain damage. Therefore, a broad literature search strategy was used with the 
intention of discovering articles focusing on a range of methods of assessment, including 
neurological, neuropsychological, psychosocial, physical and nutritional assessments in 
individuals with ARBD.  
 The databases were searched using EBSCOHOST by entering combinations of the following 
search criteria: alcohol-related brain damage/Korsakoff*/Korsakoff’s syndrome/Wernicke-
Korsakoff AND assessment. Google Scholar was also searched using combinations of the 
key words alcohol-related brain damage/Korsakoff*/Korsakoff’s syndrome/Wernicke-
Korsakoff AND assessment/“test battery,” to identify additional relevant journal articles for 
inclusion in the review. Additional database searches were conducted using combinations of 
the following search terms: Korsakoff*/Korsakoff’s Syndrome/Wernicke-Korsakoff AND 
quality of life/depression/anxiety/nutrition*, to locate additional journal articles focusing on 
the assessment of psychological and nutritional status in individuals with alcohol-related 
brain damage. A Google Scholar search revealed 1 further article which was suitable for 
inclusion in the review. Thus, a total of 177 references were retrieved from the online search, 
17 of which were duplicates, leaving a total of 160 articles to be screened for eligibility for 
inclusion in the review.  
 
The titles and abstracts for each article were screened according to the following criteria: 
Inclusion criteria 
1. Human study population 
2. Primary research study or systematic literature review 
3. Papers published in English 
4. Participants diagnosed with alcoholic Korsakoff syndrome according to DSM IV or 
ICD 10 diagnostic criteria 
5. Papers focusing on methods of assessment for individuals with alcohol-related brain 
damage 
Exclusion criteria 
1. Papers not published in English 
2. Participants with conditions other than alcoholic Korsakoff syndrome, such as 
dementia, acquired brain injury and psychiatric conditions such as schizophrenia 
3. Papers focusing on treatments, interventions or rehabilitation, prognosis or prevalence 
of alcohol-related brain damage, rather than methods of assessment 
 
Of the obtained references, 2 articles could not be accessed and 127 were rejected on the 
basis that they did not meet the inclusion criteria.  A further 6 papers were excluded due to 
close inspection revealing these papers did not reach eligibility criteria.  This left a total of 25 
articles to be included in the review. Of the papers included in this review, 6 examined 
neurological assessment, 17 focused on neuropsychological assessment, 1 investigated the 
assessment of quality of life and 1 paper focused on the assessment of depression and social 
and behavioural functioning.  
 
Results  
The literature search revealed a total of 25 papers which were suitable for inclusion in the 
review. 6 papers focused on neuroimaging, 17 papers used neuropsychological assessment 
methods and 2 papers incorporated psychosocial methods of assessing people with ARBD. 
None of the identified papers focused on methods of assessing physical functioning and 
nutritional status, suggesting there is currently a lack of published research concerning 
nutritional and physical methods of assessing individuals with ARBD.  A number of 
diagnostic categories were reported in the included papers, including Alcohol Amnestic 
Disorder; Alcohol-Induced Amnesic Syndrome; Alcohol-Induced Persisting Amnestic 
Disorder; Wernicke-Korsakoff Syndrome and Alcoholic Korsakoff’s Syndrome . These 
diagnoses were reported to be in accordance with Diagnostic and Statistical Manual (DSM) 
and International Classification of Diseases (ICD) criteria in some of the papers, whilst other 
papers made no reference to the diagnostic criteria used.   
  
 
Neuroimaging studies 
Details of the neuroimaging techniques used in the six neuroimaging studies are presented in 
Table 1. The methods of neuroimaging used in these studies included Magnetic Resonance 
Imaging (MRI) (Blansjaar et al, 1992; Emsley et al, 1996; Reed et al, 2003); functional MRI 
(fMRI) (Caulo et al, 2005); and positron emission tomography (PET) (Paller et al, 1997; 
Fellgiebel et al, 2003; Reed et al, 2003). All of these papers also incorporated 
neuropsychological methods of assessment, which will be discussed in the 
neuropsychological assessment section below.  Table 1 demonstrates that none of the 
neurological papers provided an evaluation of neuroimaging techniques as a means of 
assessing structural and functional brain abnormalities in individuals with ARBD.       
 
TABLE 1. ABOUT HERE 
 
Taken together, the neurological studies included in this review indicate that KS is associated 
with structural damage to subcortical cerebral regions (Emsley et al, 1996), the thalamus, 
cerebellum and mammillary bodies in the brain (Blansjaar et al, 1992; Reed et al, 2003). The 
findings also indicate that KS is associated with dysfunction in frontal, parietal and cingulate 
cortical regions (Paller et al, 1997), as well as impaired thalamic function (Fellgiebel et al, 
2003; Reed et al, 2003). A major weakness of the studies presented within this review is the 
small sample sizes, which limits the generalizability of their findings. Moreover, as only six 
neuroimaging studies were identified for this review, the current evidence relating to 
structural and functional neuropathology in KS patients is limited and caution should be 
exercised when interpreting the findings presented above. Considering advancements made in 
recent years in neuroimaging, it is also noted that some of these studies are quite old. A 
broader limitation of these studies relates to the validity of neuroimaging techniques 
themselves. In particular, questions can be raised concerning the functional specificity of 
neuroimaging techniques, as well as the consistency of findings from neuroimaging studies 
(Wager et al, 2008).  
 
Neuropsychological Assessments 
Seventeen of the papers included in this review used neuropsychological assessments to 
investigate the impact of ARBD on cognitive functioning. A range of neuropsychological 
methods of assessment were also utilised in the six neuroimaging papers discussed above. A 
total of 58 neuropsychological methods of assessment were identified across the seventeen 
neuropsychological and six neuroimaging papers. These assessment tools can be divided into 
three main areas, namely general cognitive and intellectual functioning, executive functioning 
and memory impairment. The methods of assessment utilised in these papers are presented in 
Table 2. Due to the large number of neuropsychological instruments identified within the 
reviewed papers, brief descriptions of the assessment tools occurring in three or more papers 
are provided; whilst the instruments occurring less frequently are listed as miscellaneous, 
unless the papers contained information pertaining to their psychometric properties. The most 
commonly used neuropsychological assessments in the reviewed papers were the Wechsler 
Adult Intelligence Scale (WAIS; Wechsler, 1998) and the FAS verbal fluency test (Spreen & 
Strauss, 1998), which occurred in 14 and 10 of the papers, respectively. The Wechsler 
Memory Scale (WMS; Weschler, 1987) occurred in 9 of the papers, whilst the Stroop Test 
(Golden & Freshwater, 2002) occurred in 7 papers. Moreover, the Trail Making Test (TMT; 
Reitan & Wolfson, 1993); Mini Mental State Examination (MMSE; Folstein et al, 1975); 
National Adult Reading Test (NART; Nelson & Willison, 1991); Wisconsin Card Sort Test 
(WCST; Kongs et al, 2000); and the Rey Osterreith Complex Figure (Osterreith, 1944) all 
occurred in 6 of the papers. 
  
TABLE 2. ABOUT HERE 
 
Table 2 reveals that the reviewed papers contain a considerable lack of information about the 
psychometric properties of the neuropsychological instruments. Details about validity and 
reliability were provided for only 7 of the 58 identified neuropsychological assessment tools. 
Most of the psychometric information about the identified neuropsychological instruments 
was provided in the paper by Maharasingam et al (2013). These authors affirmed that the 
reliability coefficients for all subtests of the WAIS-III are high and range between 0.80 and 
0.90. Maharasingam et al also stated that various versions of the NART, (Nelson & Willison, 
1991) have reliability estimates of above 0.90, making it one of the most reliable clinical tests 
of premorbid intellectual functioning. These authors also provided information about the 
inter-rater reliability of the Behavioural Assessment of the Dysexecutive Syndrome test 
(BADS) which has been demonstrated to be above 0.88 by the creators of the test. They also 
presented information about the reliability of Trail A of the TMT, (Reitan & Wolfson, 1993) 
and declared that its’ test-retest reliability is relatively high (0.79 at 11 month follow-up), 
whilst its’ inter-rater reliability is high at 0.94. Furthermore, they affirmed that the inter-rater 
reliability of the Doors and People test is very high at 0.98. Nevertheless, the information 
presented by Maharasingam et al does not specifically relate to the psychometric properties 
of these instruments in an ARBD context. Thus, there is no evidence within this paper to 
suggest that these instruments have been evaluated for use with individuals with ARBD and 
they may therefore not be appropriate for use within an ARBD context.  
Van Den Berg et al (2009) and Wester et al’s (2013) papers were the only two to investigate 
the psychometric properties of an assessment tool in relation to individuals with ARBD. 
Wester et al’s (2013) recent study aimed to evaluate the applicability of the Dutch version of 
the Rivermead Behavioural Memory Test –Third Edition (RBMT-3; Wilson et al, 2008) 
when used with individuals with KS. The findings from this study revealed that patients with 
KS performed significantly more poorly on the RBMT-3 subtests (all P-values, 0.0005) than 
healthy controls and chronic alcoholics, suggesting that this instrument is able to discriminate 
between individuals with KS and those with milder alcohol-related memory impairments.  
A Global Memory Index cut-off at 87.5 revealed that the sensitivity of the RBMT-3 was good 
at 0.8, whilst its’ specificity was adequate at 0.62. Thus, the authors of this study concluded 
that the RBMT-3 has good diagnostic accuracy when used with individuals with ARBD.  
 
Van Den Berg et al’s (2009) factor analytic study involved the collection of normative data to 
establish the validity of the Brixton Spatial Anticipation Test as a test for executive 
dysfunction in different groups of clinical patients, including 41 patients with KS. The 
Brixton Spatial Anticipation Test (Burges & Shallice, 1997) specifically measures one aspect 
of executive functioning, namely the ability to follow and detect a rule. Therefore, it is not a 
comprehensive assessment of executive dysfunction. The existing evidence for the test-retest 
reliability of the Brixton Spatial Anticipation Test indicates a coefficient of 0.71 (Burgess & 
Shallice, 1997), suggesting that the reliability of the instrument is acceptable, but not high. 
The findings from Van Den Berg et al’s study demonstrated that KS patients had impaired 
performance on the Brixton Spatial Anticipation Test in comparison to normative data from 
age and education-matched healthy controls. Moreover, as correlations were found between 
the Brixton Spatial Anticipation Test and the Trail Making Test, the authors concluded that 
the Brixton test has adequate convergent validity when used with clinical populations. The 
findings also revealed that the Brixton test had satisfactory sensitivity and specificity when 
comparing healthy controls to patients with KS (0.74), suggesting that the Brixton Spatial 
Anticipation Test could be used as an accurate diagnostic test for clients with ARBD. 
Nevertheless, as the test-retest reliability of the Brixton Spatial Anticipation Test was found 
to be relatively low (0.61), the test may not accurately measure changes over time in clinical 
populations, such as those with ARBD.  
 
The seventeen neuropsychological studies included in this review aimed to investigate the 
impact of ARBD on cognitive functioning. A wide range of neuropsychological methods of 
assessment were used to measure global cognitive and intellectual functioning, executive 
functioning and memory impairment in individuals with ARBD (See Table 2). Sixteen of the 
neuropsychological studies included in this review had between-groups designs, whilst only 
one of the studies had a longitudinal design (Fujiwara et al, 2008). Therefore, the majority of 
the studies provide no information about the cognitive changes that may occur in individuals 
with ARBD over time. Nevertheless, characteristics such as age, gender and level of 
education were controlled in most of the between-groups studies, to ensure that the control 
groups matched patients with ARBD.  
 
As a whole, the findings from the neuropsychological studies demonstrated that individuals 
with ARBD are significantly impaired on a range of cognitive functions, including memory 
and executive functions such as decision-making, time estimation, affective judgements and 
verbal fluency. The findings from these studies also suggest that despite experiencing 
profound memory impairment and executive dysfunction, general intellectual functioning 
remains relatively intact in individuals with ARBD. Nevertheless, it is clear from this review 
that the instruments used in these studies have not been validated for use within an ARBD 
context. Moreover, as the sample sizes in the studies were relatively small with numbers 
ranging from 5 (Douglas & Wilkinson, 1993) to 41 (Van Den Berg et al, 2009), the 
generalizability of their findings may be limited. 
 
Psychosocial Assessments  
Table 3 provides a summary of the psychosocial methods of assessing individuals with 
ARBD. Only two of the papers identified for inclusion in this review focused specifically on 
the use of psychosocial methods of assessing individuals with ARBD (Irvine & Mawhinney, 
2008; Oudman & Zwart, 2012). Psychosocial methods of assessment were also used in three 
of the papers discussed above (Blansjaar et al, 1992; Douglas & Wilkinson, 1997; Oscar-
Berman et al, 2004). Blansjaar et al (1992) used the Brief Psychiatric Rating Scale to screen 
for psychopathology, such as depression, anxiety and psychosis. Moreover, Douglas and 
Wilkinson (1997) used the Profile of Mood States (POMS) and the Geriatric Depression 
Scale (GDS) to assess affective state and depression severity. Oscar-Berman et al (2004) used 
the Hamilton Depression Scale (HAM-D) to measure depression severity. However, a 
systematic review of the HAM-D demonstrated that it is an insensitive measure of depression 
with several psychometric weaknesses, including poor inter-rater and test-retest reliability 
(Bagby et al, 2004). Thus, caution should be exercised when using this instrument to measure 
depression severity.  
 
TABLE 3. ABOUT HERE 
 
Oudman and Zwart (2012) used an observational dementia-specific quality of life (QoL) 
instrument called the Qualidem scale in their study. The psychometric properties of the 
Qualidem questionnaire have been evaluated in the context of dementia (Ettema et al, 2007; 
Bouman et al, 2011). Nevertheless, as Oudman and Zwart’s study is the only published 
article focusing on QoL in patients with KS, there is limited evidence for the clinical utility of 
this instrument in an ARBD context. Oudman and Zwart’s findings demonstrated that KS 
patients QoL was moderate (mean = 70%), with KS patients scoring better than patients with 
dementia on the “restless tense behaviour,” “social relations,” “having something to do” and 
“positive affect” subscales. However, KS patients scored significantly lower than those with 
dementia on the “feeling at home” subscale. Thus, although patients with KS displayed an 
overall better QoL than those with dementia, the evidence from Oudman et al’s (2012) paper 
suggests that patients with KS do not feel at home in traditional nursing home facilities.   
 
A 12-month longitudinal study by Irvine & Mawhinney (2008) used two subscales of the Life 
Skills Profile (LSP), along with the Center for Epidemiologic Studies Depression (CES-D) 
scale, to investigate changes in social and behavioural functioning in four males with KS 
(aged 38-57) living in a specialist supported living unit in Northern Ireland. The LSP is a 
strengths-based instrument which focuses on what people are capable of doing by measuring 
their functioning on a four-point scale. Although the LSP was originally developed for 
individuals with schizophrenia, it has been used to measure functioning in a range of client 
groups (Rosen et al, 2006). Irvine and Mawhinney included the “self-care ability” and “social 
contact” subscales of the Life Skills Profile (LSP), although they provided no rational for the 
omission of the “communication,” “anti-social” and “responsibility” subscales. The findings 
revealed that self-care ratings were above mid-range at baseline and fluctuated slightly over 
the 12-month study period due to mental health and behavioural issues. Moreover, social 
contact scores were low but relatively stable over the study period. Depression severity, as 
measured by the CES-D also fluctuated in this study, with 3 of the participants remaining 
within the severe depression range over the study period. The CES-D scale is a valid 20-item 
measure of depressive symptomatology with high internal consistency and adequate test-
retest reliability (Radloff, 1977). It was originally developed for use with the general 
population and its’ psychometric properties have been evaluated in relation to various clinical 
conditions, including depression and dementia. Nevertheless, as the CES-D has not been 
validated for use with individuals with ARBD caution should be exercised when interpreting 
Irvine and Wawhinney’s findings.   
 
Discussion 
This review indicates that researchers use a variety of assessment tools to investigate the 
neurological, cognitive and psychosocial impact of ARBD. The papers included in the review 
provide limited information about the validity and reliability of the instruments used to assess 
individuals with ARBD. Most of the papers focused on explaining the nature of the 
impairments resulting from ARBD, rather than evaluating the psychometric properties of the 
instruments used to assess these impairments. Thus, the clinical utility of the identified 
instruments is unknown within an ARBD context. The majority of the papers included in the 
review used neuropsychological methods of assessment, whilst six papers used neuroimaging 
techniques and four of the papers used psychosocial assessment tools. Taken together, these 
findings indicate that the existing evidence for the comprehensive assessment of individuals 
with ARBD is limited and there is a clear need for further research to be conducted to 
establish a robust evidence base in this area. It is salient that mental health nurses hold 
awareness of the utility of instruments that can be used to measure neurological, cognitive 
and psychosocial impact of ARBD. There is also room for research to be conducted to 
measure improvement and deterioration of clients’ condition in response to scheduled 
treatment protocols designed and implemented to help them control their alcohol intake.  
 
Within the reviewed papers, the two most frequently occurring neuropsychological 
assessment tools were the Wechsler Adult Intelligence Scale and the FAS Test, followed by 
the Wechsler Memory Scale (WMS), the Stroop Test, the Trail Making Test (TMT), the Mini 
Mental State Examination (MMSE), the National Adult Reading Test (NART), the 
Wisconsin Card Sort Test (WCST) and the Rey Osterreith Complex Figure. Information was 
provided about the psychometric properties of the Brixton Spatial Anticipation Test and 
Doors and People Test. However, these instruments occurred only once in the reviewed 
papers. The only instruments to be evaluated for use with individuals with ARBD were the 
Brixton Spatial Anticipation Test (Van Den Berg, 2009) and the Rivermead Behavioural 
Memory Test (Wester et al, 2013). It is important that mental health nurses are aware that 
these assessment tools do not provide a comprehensive assessment of individuals with 
ARBD, as the Brixton test assesses only one aspect of executive functioning; whilst 
Rivermead Behavioural Memory Test does not assess semantic and working memory. The 
lack of psychometric information in the reviewed papers raises the possibility that researchers 
and mental health practitioners may commonly use instruments which are not validated for 
use with individuals with ARBD. Thus, it can be argued that the findings from these papers 
should be interpreted with caution. It is also an area for further research by mental health 
nurses and addiction experts.  
 
Beyond the context of ARBD, there is mixed psychometric data for the most commonly used 
instruments identified in this review. The validity and reliability of the MMSE, WAIS and 
WMS are well established (Chlebowski, 2011; Saklofske & Schoenberg, 2011; Schatz, 
2011). Moreover, the TMT has been found to be a highly sensitive measure of attention when 
used with people with brain injury (Meyers, 2011). The reliability of the Stroop colour-word 
test has been demonstrated to be acceptable (Rozenblatt, 2011). The reliability of the NART 
has been demonstrated to be high, although its’ validity has not been established (Venegas & 
Clark, 2011). The validity and reliability of the WCST have been found to fluctuate 
depending on the level of skill and training of the administrator, and researchers have 
acknowledged that practice effects are a key limitation of this instrument when it is repeated 
multiple times (Kolakowsky-Hayner, 2011). Moreover, findings have been inconsistent for 
the validity and reliability of the FAS verbal fluency test when used with individuals with 
neurological damage, suggesting it may not be an appropriate instrument to use with 
individuals with ARBD (Patterson, 2011).  
 
The six neuroimaging studies included in this review provided information about the impact 
of ARBD on the structure and function of the brain. However, whilst neuroimaging research 
is a useful means of investigating the neuropathology of ARBD, neuroimaging techniques 
may not be financially feasible or practicable within a clinical context.  Neuroimaging may 
also be of limited value as a means of informing interventions for individuals with ARBD, as 
the consistency of findings from neuroimaging studies and the functional specificity of the 
techniques have been questioned (Wager et al, 2008). Further primary research and meta-
analysis is therefore warranted to synthesise the findings from neuroimaging studies (Wager 
et al, 2008), and to provide robust evidence for the validity and value of undertaking 
neuroimaging assessments within an ARBD context. The existing psychometric data for the 
psychosocial instruments identified in this review is limited. Several psychometric 
weaknesses have been reported for the HAM-D as a measure of depression (Bagby et al, 
2004). Moreover, as the Qualidem, LSP and CES-D have not specifically been evaluated for 
use within an ARBD context, they may not be appropriate methods of assessing quality of 
life, life skills and depression severity in individuals with ARBD. 
 
As a whole, the reviewed papers have several limitations which make it difficult to ascertain 
which instruments are most appropriate for undertaking a comprehensive assessment of 
individuals with ARBD. Firstly, there appears to be little validation for the use of the 
identified assessment tools in an ARBD context, as the existing research focusing specifically 
on evaluating the psychometric properties of assessment tools in an ARBD context is limited. 
The small sample sizes in the reviewed studies suggest that the existing evidence may be of 
limited generalizability, as the samples in the reviewed studies may have been biased. 
Despite experiencing impaired functioning during everyday life, individuals have been 
demonstrated to perform within the normal range on traditional neuropsychological tests, 
such as the Wisconsin Card Sorting Test and Stroop Test (Rozenblatt, 2011). Therefore, 
questions can be raised about the extent to which the identified neuropsychological 
assessments are able to predict everyday functioning in individuals with ARBD (Shallice & 
Burgess, 1991). Two ecologically valid neuropsychological assessment tools are the 
Behavioural Assessment of the Dysexecutive Syndrome (BADS) and the Rivermead 
Behavioural Memory Test (RBMT-3), which provide information about the everyday 
problems individuals may encounter as a result of executive dysfunction and memory 
impairment (Norris & Tate, 2000; Wester et al, 2013). These instruments may therefore be 
valuable within a clinical ARBD context, as they can be used by practitioners to identify 
problems in daily functioning, which can then be targeted in interventions (Rozenblatt, 2011).  
 
This review revealed that there is a lack of evidence for the nutritional and physical 
assessment of individuals with ARBD. Comorbidities such as liver dysfunction may explain 
this lack of evidence (Zahr et al, 2011), as research focusing on physical and nutritional 
methods of assessment may incorporate heterogeneous samples comprising of alcoholics who 
may or may not also have ARBD. If this is case, the use of wider search parameters within 
this review may have identified research pertaining to nutritional and physical methods of 
assessing individuals who have physical problems as a result of chronic alcohol misuse.  
 The papers included in this review provided no information about how often assessments 
should be repeated with individuals with ARBD. Moreover, few papers measured changes in 
functioning over time. Nevertheless, as functioning can be expected to improve to some 
extent in approximately three-quarters of individuals with ARBD (Kopelman et al, 2009), it 
has been recommended that individuals with ARBD should be assessed at least every six 
months for a period at least two years (Bruce & Ritson, 1998; Smith & Hillman, 1999; 
Jacques & Stevenson, 2000; MacRae & Cox, 2003). Important considerations when 
undertaking repeated assessments are test-retest reliability and practice effects. Thus, 
instruments with good test-retest reliability should be chosen and practice effects should be 
avoided by establishing the optimum frequency for undertaking repeated assessments within 
an ARBD context. 
 
One of the key implications arising from this review is that further research is needed to 
identify a comprehensive battery of assessments which can be used specifically with 
individuals with ARBD. There are opportunities herein for mental health nurses to develop 
and measure success of delivering particularised care schedules and specialist assessment 
packages. The development of a specialist assessment package for ARBD has implications 
for health and social care practice, as it could be used to measure and monitor the impact of 
ARBD over time and could also be used to inform evidence-based interventions. The creation 
of a comprehensive assessment package for individuals with ARBD also has implications at a 
policy level, as it could be incorporated into alcohol strategy documents, as well as clinical 
guidelines relating to the assessment and rehabilitation of individuals with ARBD by mental 
health teams in addiction units. 
 
 
 
Conclusion 
This review indicates that a variety of methods have been utilised to assess individuals with 
ARBD, despite the absence of validation for these instruments within an ARBD context. The 
review also revealed that most of the existing ARBD research uses neuropsychological 
methods of assessment, whilst there is limited evidence for the use of psychosocial 
assessments and a clear lack of evidence focusing on nutritional and physical methods of 
assessing individuals with ARBD. This review highlights the importance of ensuring that 
assessment tools are valid and reliable for use within an ARBD context. Moreover, as the 
majority of individuals with ARBD can be expected to improve to some degree, instruments 
must be able to accurately measure changes in functioning over time. This review 
demonstrates that there is currently no comprehensive assessment battery for use specifically 
within an ARBD context. Thus, there is a clear need for the development of a specialist 
assessment package to measure and monitor functioning in individuals with ARBD, and to 
inform holistic evidence-based interventions for this client group. This area of development 
lends itself to both clinical application and research development by mental health nurses 
working in the area of addictions. Protocols for scheduled treatment of chronic alcohol 
consumption and application of instruments to measure effectiveness at reducing ARBD may 
be developed, adjacent to validating and reliability testing of measuring tools involved using 
psychometrics.  
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Table 1: Neurological methods of Assessments for ARBD 
 
 
Method of Assessment 
 
 
Brief Description of instrument 
Number of 
papers using 
assessment 
Method of assessment 
evaluated within 
reviewed papers? 
Papers: Blansjaar et al, 1992 [1]; Caulo et al, 2005 [2]; Emsley et al, 1996 [3]; Fellgiebel et al, 2003 [4]; Paller et al, 1997 [5]; Reed et al, 2003 [6] 
Magnetic Resonance 
Imaging (MRI) 
Structural neuroimaging technique which 
detects lesions in the brain by providing 
cross-sectional images 
3 [1,3,6] No 
Functional Magnetic 
Resonance Imaging (fMRI) 
Functional neuroimaging technique which 
generates a spatial map of the brain to show 
areas of neural activation 
1 [1] No 
Positron Emission 
Tomography (PET) 
Functional neuroimaging technique 
involving the generation of a 2-dimensional 
colour coded map depicting the 
physiological processes within the brain 
3 [3,4,5] No 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Neuropsychological Methods of Assessments for ARBD 
 
 
Method of Assessment 
 
 
Brief Description of instrument 
Number of 
papers using 
assessment 
Method of assessment 
evaluated within 
reviewed papers? 
Papers: Beaunieux et al, 1998 [7]; Brand et al, 2003 [8]; Brand et al, 2005 [9]; Douglas and Wilkinson, 1997 [10]; Fujiwara et al, 2008 [11]; Joyce & Robbins, 1991 [12]; Kessler et al, 
1986 [13]; Labudda et al, 2010 [14]; Maharasingam et al, 2013 [15]; Oscar-Berman et al, 2004 [16]; Pitel et al, 2008 [17]; Schoenberg et al, 2010 [18]; Taylor & O’Carroll, 1995 [19]; Van 
Den Berg et al, 2009 [20]; Van Oort and Kessels, 2009 [21]; Wester et al, 2013 [22]; Wetzel & Squire, 1982 [23] 
Methods of assessing global cognitive and intellectual functioning 
Mini Mental State 
Examination (MMSE) 
Brief 11-item quantitative screening test to 
assess the severity of cognitive impairment. 
The MMSE  takes 5 to 10 minutes to 
complete 
6 [5,8.9,11,14,17] No 
Wechsler Adult 
Intelligence Scale (WAIS) 
Comprehensive intellectual functioning 
assessment battery comprising 6 “verbal” 
and 5 “performance” subtests  
14 
[1,3,5,6,7,8,9,10,11,13,1
4,15,16,17] 
Reliability coefficient > 
0.80 
National Adult Reading 
Test (NART) 
50-word untimed pronunciation test which 
provides an estimate of premorbid 
intellectual functioning 
6 [5,6,9,11,12,15] Reliability coefficient > 
0.90 
Miscellaneous assessments include: Achievement Measurement System; Clinical Dementia Rating Scale; Graded Naming 
Test; Groningen Intelligence Test; Leistungsprufsystem; Mehrfach-Wahl-Wortschatztest; Oklahoma Premorbid Intelligence 
Estimate-3 (OPIE-3); Raven’s Standard Progressive Matrices 
Methods of assessing executive functioning 
Behavioural Assessment of 
the Dysexecutive 
Syndrome (BADS) 
20-item test of executive functioning 
comprising 6 subtests, designed to assess 
everyday problems arising from executive 
dysfunction 
2 [15,21] Inter-rater reliability 0.88 
Trail Making Test (TMT) Test of attention, information processing 
speed and cognitive flexibility. The test 
comprises Trails and B and there is a time 
limit of 5 mintues per trail 
6 [3,10,11,14,15,16] Reliability coefficient 0.79 
Inter-rater reliability 0.94 
Word Naming (FAS) Test Phonemic verbal fluency test assessing the 
generation of words beginning with F, A 
and S, with 60-seconds allocated for each 
word 
10 [3,5,6,8,9,11,12, 
14,16,17] 
No 
Wisconsin Card Sorting 
Test (WCST) 
Non-verbal card sorting test assessing 
abstract reasoning, mental flexibility and 
problem solving. The WCST takes 
approximately 15 minutes to administer and 
10 minutes to score by hand 
6 [5,8,9,12,14,16] No 
Stroop Test Brief word-colour interference test 
assessing the ability to inhibit a habitual 
response to colour-word stimuli 
 7 [1,5,7,8,9,14,17] No 
Brixton Spatial 
Anticipation Test (BSAT) 
Non-verbal test that assesses mental 
flexibility and verbal memory. The test 
takes around 10 minutes to administer 
1 [14] Construct validity 
coefficient = 0.74;  Test-
retest reliability = 0.61 
Miscellaneous assessments include: Game of Dice Task; Porteus Mazes; Progressive Planning Test; Ruff Figural Fluency 
Test; Test for Cognitive Estimation; Tower of Hanoi puzzle; Tower of London task  
Methods of assessing memory impairment 
Wechsler Memory Scale 
(WMS) 
Comprehensive test comprising 5 indexes 
(general memory, verbal memory, visual 
memory, attention/concentration and 
delayed recall) 
9 
[1,3,5,6,7,10,12,13,16] 
No 
Memo Test Memory test assessing immediate and 
delayed recall 
4 [8,9,11,14] No 
Rey Osterreith Complex 
Figure 
Non-verbal test of visual memory, 
visuospatial construction ability and 
executive functioning 
6 [2,3,7,8,9,11] No 
Fragmented Pictures Test Test of implicit memory 3 [8,9,11] No 
Doors and People Long-term memory test comprising 4 
categories (doors, people, shapes and 
names), which assesses visual and verbal 
recognition and recall. The test takes 
approximately 40 minutes to administer 
1 [15] Inter-rater reliability 0.98 
Rivermead Behavioural 
Memory Test 
Test of everyday memory deficits which 
assesses verbal/nonverbal episodic 
memory, spatial memory, prospective 
memory and procedural memory 
2 [21,22] Global Memory Index test 
sensitivity (≥0.8) 
Global Memory Index test 
specificity (≥0.6)   
Miscellaneous assessments include: Auditory-Verbal Learning Test; Behavioural Face Recall and Recognition tests; Brown-
Peterson Paradigm; Cambridge Mental Disorders of the Elderly Examination; Corsi Block Tapping Task; Test; Ecological 
Memory Test; Grober and Buschke Test; Memory Assessment Scales; Mirror Reading Test; N-2 paradigm; Public Events 
Recognition List; Warrington Recognition Memory Test; Williams delayed Recall Test; Reading Speed Priming Test; 
Release from Proactive Interference; Remember/Know/Guess Paradigm; Rey Auditory Verbal Learning Test; Signoret’s 
Memory Battery; Spondee Test; Verbal and Spatial Span tasks 
Other methods of assessment include:  Affective Word Test; Cambridge Neuropsychological Test Automated Battery; 
Concurrent Object Discrimination Task; Emotional Picture Task; Semantic Classification Test; Test Battery for Attentional 
Performance; Visual Object Space Perceptual Battery (VOSP) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Psychosocial Methods of Assessment 
 
 
Method of Assessment 
 
 
Brief Description of instrument 
Number of 
papers using 
assessment 
Method of assessment 
evaluated within 
reviewed papers? 
Papers: Blansjaar et al, 1992 [1]; Douglas & Wilkinson, 1997 [10]; Oscar-Berman et al, 2004 [16] Irvine and Wawhinney, 2008 [24]; Oudman and Zwart, 2012 [25] 
Qualidem scale 37-item observational Quality of Life 
(QoL) instrument with 9 subscales. The 
Qualidem was specifically developed for 
patients with mild-moderate dementia 
living in residential care.  
1 [24] Internal consistency of 
individual subscales ranges 
from 0.59-0.89 
Life Skills Profile (LSP) Standardised instrument for measuring 
social and behavioural functioning, 
comprising 5 subscales, including self-care 
ability; social contact; communication; 
responsibility and anti-social behaviour  
1 [25] No 
Center for Epidemiologic 
Studies Depression Scale 
(CES-D) 
Standardised instrument for assessing 
depression severity 
1 [24] No 
Profile of Mood States 
(POMS) 
Standardised measure of 6 affective mood 
states over time, including Tension-
Anxiety; Vigour-Activity; Depression-
Dejection; Fatigue-Inertia; Anger-Hostility; 
and Confusion-Bewilderment  
1 [10] No 
Geriatric Depression Scale Measure of depression designed for use 
with elderly long-term care patients 
1 [10] No 
Hamilton Depression Scale Standardised instrument for assessing 
depression severity 
1 [16] No 
Brief Psychiatric Rating 
Scale 
Rating scale which screens for 
psychopathology such as depression, 
anxiety and psychosis  
1 [1] No 
 
  
Figure 1: Flow of information through systematic review 
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Eligibility 
 
 
 
Included 
 
 
 
Number of references 
identified through 
database searching – 
177 
 
Number of references after 
duplicates removed –  
160 
Number of abstracts 
screened - 160 
Number of full text 
articles assessed for 
eligibility – 31  
Number of references 
excluded – 127 
 
Number of full text 
articles excluded - 6 
Number of papers 
eligible – 25  
Number of papers 
unobtainable - 2 
 
Number of papers 
included in review - 25  
